S2-E31.2 – Previewing Digital ILC 2021 — Part II — Drug Development

Stephen Harrison and Jörn Schattenberg discuss what the titles of Digital ILC 2021 presentations tell us about possible findings in drug development.

Drug development presentations will occur throughout Digital ILC 2021, ranging from late-breakers to general session presentations to dedicated sessions. Stephen and Jörn use the titles of presentation to discuss areas of drug development, paying particular attention to treating cirrhosis on one end and drugs that address defatting the liver through metabolic modes of action.

TOPICS: cirrhosis, EASL, efruxifermin, FGF-21, Madrigal, NAFLD, NASH, OCA, resmetirom, Digital ILC 2021, selonsertib, emricasan

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

Experience Nudge Learning! Interested in a new way of learning?